Biofortuna Limited

Early Stage

Biofortuna is a leading developer of HLA diagnostic test kits for the organ transplantation, blood grouping and disease identification markets.

Biofortuna has developed a unique freeze drying methodology that differentiates its product and provides tangible benefits to end users around transportation and ease of use.  Molecular diagnostics is a growing market and Biofortuna, via its experienced and renowned scientific team, is well placed to capitalise on the opportunities that this will present.

Our investment has enabled Biofortuna to launch its products, negotiate a global distribution deal and recruit a new CEO and non executive director.  In the future Biofortuna will continue to develop and expand its product range and its manufacturing capabilities.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200